Clinicopathologic analysis of amphiregulin and heregulin immunostaining in breast neoplasia

Breast Cancer Research and Treatment

Volumn 45, Issue 1, 1997, Pages 75-80

  Visscher, D W ^a,b   Sarkar, F H ^a   Kasunic, T C ^a   Reddy, K B ^a  

^a WAYNE STATE UNIVERSITY   (United States)

^b HARPER UNIVERSITY HOSPITAL   (United States)

Author keywords

Amphiregulin; Breast carcinoma; Epidermal growth factor receptor; Heregulin

Indexed keywords

AMPHIREGULIN; EPIDERMAL GROWTH FACTOR RECEPTOR; ESTROGEN RECEPTOR; NEU DIFFERENTIATION FACTOR;

ARTICLE; BREAST CARCINOMA; BREAST EPITHELIUM; CANCER RECURRENCE; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; ONCOGENE NEU; PATHOLOGY; PRIORITY JOURNAL; STROMA CELL;

BREAST NEOPLASMS; CARCINOMA; FEMALE; GLYCOPROTEINS; GROWTH SUBSTANCES; HUMANS; IMMUNOHISTOCHEMISTRY; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; NEUREGULINS;

EID: 0030876723     PISSN: 01676806     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1005845512804     Document Type: Article

References (19)

1. Shoyab M, Plowman GD, McDonald VI., Bradley JG, Todaro GJ: Structure and function of human amphiregulin: a member of the epidermal growth factor family. Science 24: 1074-1076, 1989
2. Normanno N, Ciardiello F, Brandt R, Salomon DS: Epidermal growth factor-related peptides in the pathogenesis of human breast cancer. Breast Cancer Res Treat 29: 11-27, 1994
3. Peles E, Ben-Levy R, Tzahar E, Liu N, Wen D, Yarden Y: Cell-type specific interaction of neu differentiation factor (NDF/heregulin) with neu/Her 2 suggests complex ligand-receptor relationships. EMBO J 12: 961-971, 1993
4. erb.B4, a fourth member of the epidermal growth factor receptor family. Proc Natl Acad Sci USA 90: 1746-1750, 1993
5. Sliwkowski MX, Schaefer G, Akita RW, Lofgren JA, Fitzpatrick VD, Nuijens A, Fendly BM, Cerione RA, Vandlen RL, Carraway KL III: Coexpression of erbB-2 and erbB-3 proteins reconstitutes a high affinity receptor for heregulin. J Biol Chem 269: 14661-14665, 1994
6. Lupu R, Cardillo M, Cho C, Harris L, Hijazi M, Perez C, Rosenberg K, Yang D, Tang C: The significance of heregulin in breast cancer tumor progression and drug resistance. Breast Caneer Res Treat 38: 57-66, 1996
7. Marte BM, Jeschke M, Graus-Porta D, Taverna D, Hofer P, Groner B, Yarden Y, Hynes NE: Neu differentiation factor/heregulin modulates growth and differentiation of HC11 mammary epithelial cells. Mol Endo 9: 14-23, 1995
8. Fiddes RJ, Janes PW, Sanderson CM, Sivertsen SP, Sutherland RL, Day RJ: Heregulin (HRG)-induced mitogenic signaling and cytotoxic activity of a HRG/PE40 ligand toxin in human breast cancer cells. Cell Growth and Differentiation 6: 1567-1577, 1995
9. Normano N, Selvam MP, Qi C-F, Saeki T, Johnson G, Kim N, Ciardiello F, Shoyab M, Plowman G, Brandt R, Todaro G, Salomon DS: Amphiregulin as an autocrine growth factor for c-Ha-ras and c-erbB-2-transformed human mammary epithelial cells. Proc Natl Acad Sci USA 91: 2790-2794, 1994
10. Johnson GR, Saeki T, Gordon AW, Shoyab M, Salomon DS, Stromberg K: Autocrine action of amphiregulin in a colon carcinoma cell line and immuno-cytochemical localization of amphiregulin in human colon. J Cell Biol 118: 741-751, 1992
11. Normanno N, Kim N, Wen D, Smith K, Harris AL, Plowman G, Coletta G, Ciardiello F, Salomon DS: Expression of messenger RNA for amphiregulin, heregulin, and cripto-1, three new members of the epidermal growth factor family, in human breast carcinomas. Breast Cancer Res Treat 35: 293-297, 1995
12. Ruddy KB, Mangold GL, Tandon AK, Yoneda T, Mundy OR, Zilberstein A, Osborne CK: Inhibition of breast cancer cell growth in vitro by tyrosine kinase inhibitor. Cancer Res 52: 3636-3641, 1992
13. Reddy KB, Yee D, Coffey RJ, Hilsenbeek SG, Osborne CK: Inhibition of estrogen-induced breast cancer cell proliferation by reduction in autocrine transforming growth factor a expression. Cell Growth Differentiation 5: 1275-1282, 1994
14. LeJeune S, Leek R, Horak E, Plowman G, Greenall M, Harris AL: Amphiregulin, epidermal growth factor receptor, and estrogen receptor expression in human primary breast cancer. Cancer Res 53: 3597-3602, 1993
15. Qi C-F, Liscia DS, Normanno N, Merlo G, Johnson GR, Gullick WJ, Ciardiello F, Saeki T, Brandt R, Kim N, Kenney N, Salomon DS: Expression of transforming growth factor α, amphiregulin and cripto-1 in human breast carcinomas. Br J Cancer 69: 903-910, 1994
16. Weidner N, Folkman J, Possa F, Bevilacqua P, Allred EN, Moore DH, Meli S, Gasparini G: Tumor angiogenesis: a new significant and independent prognostic indicator in early-stage breast carcinoma. J Natl Cancer Inst 84(24): 1875-1887
17. Catellani R, Visscher DW, Wykes S, Sarkar FH, Crissman JD: Interaction of transforming growth factor-alpha and epidermal growth factor receptor in breast cancer. Cancer 73: 344-349, 1994
18. Shoyab M, McDonald VL, Bradley JG, Todaro GJ: Amphiregulin: a bifunctional growth-modulating glycoprotein produced by the phorbol 12-myristate 13-acetate-treated human breast adenocareinoma cell line MCF-7. Proc Natl Acad Sci USA 85: 6528-6532, 1988
19. Plowman GD, Green JM, McDonald VL, Neubauer GM, Disteche CM, Todaro GJ, Shoyab M: The amphiregulin gene encodes a novel epidermal growth factor-related protein with tumor-inhibitory activity. Mol Cell Biol 10: 1969-1981, 1990